Copyright Reports & Markets. All rights reserved.

Global Drugs for Pain Management Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Drugs for Pain Management
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drugs for Pain Management by Type
    • 1.3.1 Overview: Global Drugs for Pain Management Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Drugs for Pain Management Consumption Value Market Share by Type in 2023
    • 1.3.3 Generic Opioid
    • 1.3.4 Branded Opioids
    • 1.3.5 NSAIDs
    • 1.3.6 Others
  • 1.4 Global Drugs for Pain Management Market by Application
    • 1.4.1 Overview: Global Drugs for Pain Management Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Drugstores
    • 1.4.4 Others
  • 1.5 Global Drugs for Pain Management Market Size & Forecast
  • 1.6 Global Drugs for Pain Management Market Size and Forecast by Region
    • 1.6.1 Global Drugs for Pain Management Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Drugs for Pain Management Market Size by Region, (2019-2030)
    • 1.6.3 North America Drugs for Pain Management Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Drugs for Pain Management Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Drugs for Pain Management Market Size and Prospect (2019-2030)
    • 1.6.6 South America Drugs for Pain Management Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Drugs for Pain Management Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Drugs for Pain Management Product and Solutions
    • 2.1.4 GSK Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 GSK Recent Developments and Future Plans
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Drugs for Pain Management Product and Solutions
    • 2.2.4 Pfizer Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Pfizer Recent Developments and Future Plans
  • 2.3 Grunenthal
    • 2.3.1 Grunenthal Details
    • 2.3.2 Grunenthal Major Business
    • 2.3.3 Grunenthal Drugs for Pain Management Product and Solutions
    • 2.3.4 Grunenthal Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Grunenthal Recent Developments and Future Plans
  • 2.4 Sanofi
    • 2.4.1 Sanofi Details
    • 2.4.2 Sanofi Major Business
    • 2.4.3 Sanofi Drugs for Pain Management Product and Solutions
    • 2.4.4 Sanofi Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Sanofi Recent Developments and Future Plans
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer Drugs for Pain Management Product and Solutions
    • 2.5.4 Bayer Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bayer Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Drugs for Pain Management Product and Solutions
    • 2.6.4 AstraZeneca Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Eli Lilly
    • 2.7.1 Eli Lilly Details
    • 2.7.2 Eli Lilly Major Business
    • 2.7.3 Eli Lilly Drugs for Pain Management Product and Solutions
    • 2.7.4 Eli Lilly Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Eli Lilly Recent Developments and Future Plans
  • 2.8 Endo
    • 2.8.1 Endo Details
    • 2.8.2 Endo Major Business
    • 2.8.3 Endo Drugs for Pain Management Product and Solutions
    • 2.8.4 Endo Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Endo Recent Developments and Future Plans
  • 2.9 Merck
    • 2.9.1 Merck Details
    • 2.9.2 Merck Major Business
    • 2.9.3 Merck Drugs for Pain Management Product and Solutions
    • 2.9.4 Merck Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Merck Recent Developments and Future Plans
  • 2.10 Yunnan Baiyao
    • 2.10.1 Yunnan Baiyao Details
    • 2.10.2 Yunnan Baiyao Major Business
    • 2.10.3 Yunnan Baiyao Drugs for Pain Management Product and Solutions
    • 2.10.4 Yunnan Baiyao Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Yunnan Baiyao Recent Developments and Future Plans
  • 2.11 Teikoku Seiyaku
    • 2.11.1 Teikoku Seiyaku Details
    • 2.11.2 Teikoku Seiyaku Major Business
    • 2.11.3 Teikoku Seiyaku Drugs for Pain Management Product and Solutions
    • 2.11.4 Teikoku Seiyaku Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Teikoku Seiyaku Recent Developments and Future Plans
  • 2.12 Teva
    • 2.12.1 Teva Details
    • 2.12.2 Teva Major Business
    • 2.12.3 Teva Drugs for Pain Management Product and Solutions
    • 2.12.4 Teva Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Teva Recent Developments and Future Plans
  • 2.13 J&J
    • 2.13.1 J&J Details
    • 2.13.2 J&J Major Business
    • 2.13.3 J&J Drugs for Pain Management Product and Solutions
    • 2.13.4 J&J Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 J&J Recent Developments and Future Plans
  • 2.14 Assertio Therapeutics
    • 2.14.1 Assertio Therapeutics Details
    • 2.14.2 Assertio Therapeutics Major Business
    • 2.14.3 Assertio Therapeutics Drugs for Pain Management Product and Solutions
    • 2.14.4 Assertio Therapeutics Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Assertio Therapeutics Recent Developments and Future Plans
  • 2.15 Allergan
    • 2.15.1 Allergan Details
    • 2.15.2 Allergan Major Business
    • 2.15.3 Allergan Drugs for Pain Management Product and Solutions
    • 2.15.4 Allergan Drugs for Pain Management Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Allergan Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drugs for Pain Management Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Drugs for Pain Management by Company Revenue
    • 3.2.2 Top 3 Drugs for Pain Management Players Market Share in 2023
    • 3.2.3 Top 6 Drugs for Pain Management Players Market Share in 2023
  • 3.3 Drugs for Pain Management Market: Overall Company Footprint Analysis
    • 3.3.1 Drugs for Pain Management Market: Region Footprint
    • 3.3.2 Drugs for Pain Management Market: Company Product Type Footprint
    • 3.3.3 Drugs for Pain Management Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drugs for Pain Management Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Drugs for Pain Management Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Drugs for Pain Management Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Drugs for Pain Management Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Drugs for Pain Management Consumption Value by Type (2019-2030)
  • 6.2 North America Drugs for Pain Management Consumption Value by Application (2019-2030)
  • 6.3 North America Drugs for Pain Management Market Size by Country
    • 6.3.1 North America Drugs for Pain Management Consumption Value by Country (2019-2030)
    • 6.3.2 United States Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Drugs for Pain Management Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Drugs for Pain Management Consumption Value by Type (2019-2030)
  • 7.2 Europe Drugs for Pain Management Consumption Value by Application (2019-2030)
  • 7.3 Europe Drugs for Pain Management Market Size by Country
    • 7.3.1 Europe Drugs for Pain Management Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 7.3.3 France Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Drugs for Pain Management Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drugs for Pain Management Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Drugs for Pain Management Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Drugs for Pain Management Market Size by Region
    • 8.3.1 Asia-Pacific Drugs for Pain Management Consumption Value by Region (2019-2030)
    • 8.3.2 China Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 8.3.5 India Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Drugs for Pain Management Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Drugs for Pain Management Consumption Value by Type (2019-2030)
  • 9.2 South America Drugs for Pain Management Consumption Value by Application (2019-2030)
  • 9.3 South America Drugs for Pain Management Market Size by Country
    • 9.3.1 South America Drugs for Pain Management Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Drugs for Pain Management Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drugs for Pain Management Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Drugs for Pain Management Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Drugs for Pain Management Market Size by Country
    • 10.3.1 Middle East & Africa Drugs for Pain Management Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Drugs for Pain Management Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Drugs for Pain Management Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Drugs for Pain Management Market Drivers
  • 11.2 Drugs for Pain Management Market Restraints
  • 11.3 Drugs for Pain Management Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drugs for Pain Management Industry Chain
  • 12.2 Drugs for Pain Management Upstream Analysis
  • 12.3 Drugs for Pain Management Midstream Analysis
  • 12.4 Drugs for Pain Management Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drugs for Pain Management market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 42650 million by 2030 with a CAGR of 2.3% during review period.
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
    This report is mainly about the drugs for pain management.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Drugs for Pain Management industry chain, the market status of Hospitals (Generic Opioid, Branded Opioids), Drugstores (Generic Opioid, Branded Opioids), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drugs for Pain Management.
    Regionally, the report analyzes the Drugs for Pain Management markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drugs for Pain Management market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Drugs for Pain Management market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drugs for Pain Management industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Generic Opioid, Branded Opioids).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drugs for Pain Management market.
    Regional Analysis: The report involves examining the Drugs for Pain Management market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drugs for Pain Management market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Drugs for Pain Management:
    Company Analysis: Report covers individual Drugs for Pain Management players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drugs for Pain Management This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Drugstores).
    Technology Analysis: Report covers specific technologies relevant to Drugs for Pain Management. It assesses the current state, advancements, and potential future developments in Drugs for Pain Management areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drugs for Pain Management market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Drugs for Pain Management market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Generic Opioid
    Branded Opioids
    NSAIDs
    Others
    Market segment by Application
    Hospitals
    Drugstores
    Others
    Market segment by players, this report covers
    GSK
    Pfizer
    Grunenthal
    Sanofi
    Bayer
    AstraZeneca
    Eli Lilly
    Endo
    Merck
    Yunnan Baiyao
    Teikoku Seiyaku
    Teva
    J&J
    Assertio Therapeutics
    Allergan
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Drugs for Pain Management product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Drugs for Pain Management, with revenue, gross margin and global market share of Drugs for Pain Management from 2019 to 2024.
    Chapter 3, the Drugs for Pain Management competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drugs for Pain Management market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for Pain Management.
    Chapter 13, to describe Drugs for Pain Management research findings and conclusion.

    Buy now